Cryo-Save Group NV: Girl with cerebral palsy treated with own cord blood stem cells

28 juli 2011 Girl with Cerebral palsy treated with own cord blood stem cells Cryo-Save Group N.V. (Euronext: CRYO, "Cryo-Save"), Europe's leading family stem cell bank, released a cord blood sample of a six-year-old girl from Portugal.  The girl will be treated with her own umbilical cord blood stem cells at Duke University (USA) for cerebral palsy (CP). Cerebral palsy refers to a number of neurological disorders that appear in infancy or early childhood and permanently affects body movement and muscle coordination. It is a serious brain injury for which there is no standard cure available.  The little girl received the first reinfusion of her own stem cells earlier this week. Ground breaking medical treatment Medical doctors at Duke University are treating cerebral palsy patients who have their own cord blood stored, in a clinical trial. In a simple and safe procedure, the stem cells from umbilical cord blood that were stored at birth are transfused back into the children, in what is called an autologous stem cell transfusion (using one's own stem cells). Parents have noticed significant improvements in their children who suffer from cerebral palsy after receiving their own cord blood transfusion and this and other similar trials around the world hope to show conclusive evidence. Treatment of diseases with one's own stem cells is increasing Arnoud van Tulder, Chief Executive Officer, commented: "Cryo-Save is proud to again be able to make a difference and contribute to improve the life of a child. The number of applications for autologous use of cord blood stem cells is increasing: having samples requested for release, accepted by hospitals and successfully transfused shows the importance of a high quality stem cell bank. Cryo-Save is proud to ensure the highest standards from collecting, transport, processing and storing." Enquiries: Cryo-Save Group + 31 (0) 575 548 998 Arnoud van Tulder, Chief Executive Officer SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181 Kees Jongsma/Leon Melens Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550 Sean Lunn College Hill (UK) + 44 (0) 20 7457 2020 Rozi Morris/ Adrian Duffield Free footage is available on www.videobankonline.com About Cryo-Save (www.cryo-save.com/group) Cryo-Save, the leading international family stem cell bank, already stores more than 175,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be cured by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India, South Africa and France (validation in progress). click here for PFD press release: http://hugin.info/143308/R/1534071/467457.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Cryo-Save Group N.V. via Thomson Reuters ONE [HUG#1534071]